Skip to main content

Table 1 Patient characteristics (n = 226)

From: Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients

Age at HTx, mean ± SD, years

 

 Recipient (R)

45 ± 13

 Donor (D)

33 ± 12

Male gender, n (%)

 

 Recipient

176 (78)

 Donor

159 (70)

Body mass index at HTx, mean ± SD kg/m2

23.8 ± 3.9

Cold ischemic time, mean ± SD minutes CMV serology, n (%)

168 ± 49

 D+ /R−

46 (20)

 D+ /R+

101 (45)

 D− /R+

64 (28)

 D− /R−

15 (7)

Induction therapy, n (%)

 

 CsA

48 (21)

 ATG

165 (73)

 Daclizumab

4 (2)

 Prednisone

9 (4)

CAD, n (%)

73 (32)

Hypertension, n (%)

30 (13)

Diabetes Mellitus, n (%)

23 (10)

Previous smoking, n (%)

127 (56)

TRS at 1 year, mean ± SD

0.49 ± 0.30

TRS ≥ 2R at 1 year, mean ± SD

0.22 ± 0.20